# Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

> **NCT01421875** · — · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 257 (actual)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** DNA methylation analysis
- **GENETIC:** RNA analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **GENETIC:** nucleic acid sequencing
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01421875
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-17
- **Primary completion:** 2011-10-17
- **Final completion:** 2011-10-17
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01421875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01421875, "Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01421875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*